Venture
Enable Injections, Inc
Latest Form D 2026-01-09- CIK 1619825
- State OH
- Other Health Care
- 11 Form D offerings since 2014-09-18
- Total sold
- $245M
- across 11 offerings
- Rounds
- 11
- Form D offerings since 2014-09-18
- Latest round
- $30M
- 2026-01-09 · 021-569420
- Investors
- 1
- on the latest round
Connected
named in its Form D filingsRound timeline
amount sold · by first filed2026-01-09 · $30M
- 2014-09-18$2M021-224993
- 2016-08-02$5M021-268147
- 2016-08-11$0021-268766
- 2016-08-11$0021-268768
- 2016-08-11$247K021-268769
- 2016-08-22$2M021-269343
- 2016-08-24$22.9K021-269470
- 2016-09-01$25M021-270012
- 2018-10-30$30.7M021-324691
- 2022-02-03$150M021-432244
- 2026-01-09$30M021-569420
Hover a dot or row, or tab through the dots · bars scaled to the largest round ($150M)
Form D offerings
One line per offering, amendments folded in, newest first
| File | First filed | Latest | Sought | Sold | Investors | Exemptions |
|---|---|---|---|---|---|---|
| 021-569420 | First filed2026-01-09 | Latest2026-01-09 | Sought$30M | Sold$30M | Investors1 | Exemptions506(b) |
| 021-432244 | First filed2022-02-03 | Latest2022-02-03 | Sought$215M | Sold$150M | Investors22 | Exemptions506(b) |
| 021-324691 | First filed2018-10-30 | Latest2018-10-30 | Sought$50M | Sold$30.7M | Investors15 | Exemptions506(b) |
| 021-270012 | First filed2016-09-01 | Latest2016-11-17 | Sought$25M | Sold$25M | Investors1 | Exemptions506(b) |
| 021-269470 | First filed2016-08-24 | Latest2016-08-24 | Sought$22.9K | Sold$22.9K | Investors1 | Exemptions504 |
| 021-269343 | First filed2016-08-22 | Latest2016-08-22 | Sought$2M | Sold$2M | Investors13 | Exemptions506(b) |
| 021-268769 | First filed2016-08-11 | Latest2016-08-17 | Sought$247K | Sold$247K | Investors0 | Exemptions506(b) |
| 021-268768 | First filed2016-08-11 | Latest2016-08-17 | Sought$9.6K | Sold$0 | Investors0 | Exemptions506(b) |
| 021-268766 | First filed2016-08-11 | Latest2016-08-17 | Sought$100K | Sold$0 | Investors0 | Exemptions506(b) |
| 021-268147 | First filed2016-08-02 | Latest2016-08-17 | Sought$5M | Sold$5M | Investors19 | Exemptions506(b) |
| 021-224993 | First filed2014-09-18 | Latest2016-04-18 | Sought$5M | Sold$2M | Investors13 | Exemptions506(b) |
Who backs Enable Injections, Inc, inferred from co-filings, and every Form D as filedSee plans
People
Named in Item 3 of its latest Form D, filed 2026-01-09
| Name | Relationship |
|---|---|
| Timothy Flaherty | RelationshipExecutive Officer |
| Michael D. Hooven | RelationshipExecutive Officer, Director |
| Matt Huddleston | RelationshipExecutive Officer |
| David Kroekel | RelationshipExecutive Officer |
| Simone Song | RelationshipDirector |
| Erik Falk | RelationshipDirector |
| Richard J. D'Augustine | RelationshipDirector |
| Vickie Capps | RelationshipDirector |
| Jim Collins | RelationshipDirector |
| John DeFord | RelationshipDirector |
| John Rice | RelationshipDirector |
| Beckie Robertson | RelationshipDirector |
| Nigel Sheail | RelationshipDirector |
Facts
As its latest Form D states them
- Industry
- Other Health Care
- State
- Ohio (OH)
- Exemptions
- Rule 506(b); Rule 504(b)(1) (not (i), (ii) or (iii))
- First filed
- 2014-09-18
- Latest filing
- 2026-01-09
- Minimum investment
- $0K
Who backs Enable Injections, Inc
Form D names a startup's officers and directors, not its investors. The dashboard infers them — the venture funds whose own filings and people overlap this company's rounds — and lays every Form D and amendment it filed beside the totals above.
- Inferred investors — the funds and firms behind it, from co-filings and shared people
- Every Form D and amendment as filed, with what each one stated
- Its rounds in sequence: the gap between them and whether they grew
- Everyone its filings name, linked to their other companies, with its addresses and phone numbers
Part of the Venture plan — $140/mo at launch pricing ($350 list)
See plansExternal link: SEC Filings ↗